PAD Resource Center Editorial Programs

 
 
  • 15 Studies That Challenged Medical Dogma in 2018 Dr Eric Topol highlights articles that turned prevailing wisdom on its head over the past year.
  • New RBI for Kidney Allografts: Can It Replace Routine Tests? Dr Desai reviews a study examining the usefulness of a new renal biopsy index (1-RBI). Could it be used in place of invasive routine biopsies in deceased-donor kidney transplant recipients?
  • Sodium Restriction in HF: Take It With a Grain of Salt?   Despite wide acceptance, evidence to support low-sodium diets is lacking. Until we know more, keep dietary recommendations simple, says Ileana Piña, MD.
  • ECG Challenge: A Counterclockwise Rotation A woman is admitted with a bowel obstruction. What does her admission ECG show?
  • Hyperglycemia in T2D: Where's the Proof of the Pudding? Have older medications been justifiably sidelined in the ADA/EASD consensus statement on managing hyperglycemia in type 2 diabetes? Dr Aus Alzaid shares his critique of the updated guideline.
  • The Year in Neurology 2018   New studies in 2018: Dr Hans-Christoph Diener discusses recent results from studies across neurology that have led to practice changes.
  • ARBs/ACEIs After AKI: Balancing Tradeoffs Dr Bansal reviews a study that provides important data on the use of RAAS inhibitors after acute kidney injury--an understudied clinical topic.
  • The Top Cardiology Trials of 2018 in Review Contrasting studies on the benefits of percutaneous mitral valve repair and a fall from grace for aspirin make the list for Bob Harrington and Mike Gibson. Find out what else piqued their interest.
  • Mandrola's Top 10 Cardiology Stories of 2018 From blood pressure management in the community to a study on potentially biased referees -- John Mandrola reviews his picks for the year's big stories in cardiology and medicine.
  • What It Takes to Be a Top 10 Stroke Hospital Dr Andrew Wilner on how physician surveys of top hospitals provide models of success worth emulating.
  • Do Neprilysin Inhibitors Have a Role in Patients With CKD? Dr Desai reviews the UK HARP-III trial, which compares the effects of sacubitril/valsartan and irbesartan on kidney function in people with CKD.
  • Urgent Surgical Procedures: Does It Matter Who Is On Call? Dr Lowenfels comments on a study that examined whether surgical experience contributed to the outcomes of patients requiring urgent procedures.
  • More Fluoroquinolone Safety Concerns How do the most recently identified safety issues affect fluoroquinolones' place in therapy?
  • ECG Challenge: Tired and Out of Control An older woman presents with hypertension and lightheadedness. What does her ECG show?
  • How to Know When It's Autoimmune Epilepsy A conversation between Drs Andrew Wilner and Batool Kirmani on the red flags your patient may have this difficult-to-diagnosis condition.
  • 10 Little Known Uses for Common, Everyday Drugs Drugs you probably prescribe at least weekly have some benefits that are little known.
  • Multiple Myeloma: Relapse-Ready   City of Hope oncologists discuss optimal choices for treating patients with relapsed disease and report on emerging options that are changing the field.
  • ACC/AHA 2018 Cholesterol Guideline: The New and the Old   Drs Michael Blaha and Salim Virani review key takeaways from the 2018 ACC/AHA updated cholesterol guideline, noting that much is new in management of patients with elevated lipids.
  • CV Risk Assessment: A Process, Not a Calculation   Tips on how to estimate, personalize, and reclassify patient risk in light of the new cholesterol guidelines. Dr Blaha walks through a typical patient case with guideline writer Dr Lloyd-Jones
  • CV Risk: Can Prescription Omega-3 REDUCE-IT?   Low-dose omega-3 flopped for CV risk reduction. Melissa Walton-Shirley, MD, dissects the REDUCE-IT trial from AHA, which used high-dose prescription EPA, with principal investigator, Deepak Bhatt, MD.
http://pills24.com.ua

https://steroid-pharm.com

www.pills24.com.ua